Growth Metrics

China Pharma Holdings (CPHI) Exchange Rate Effect (2016 - 2025)

China Pharma Holdings filings provide 16 years of Exchange Rate Effect readings, the most recent being $3856.0 for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect rose 106.08% to $3856.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1250.0, a 101.91% increase, with the full-year FY2025 number at $1250.0, up 101.91% from a year prior.
  • Exchange Rate Effect hit $3856.0 in Q4 2025 for China Pharma Holdings, down from $42392.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $50439.0 in Q4 2023 to a low of -$153626.0 in Q3 2022.
  • Median Exchange Rate Effect over the past 5 years was -$2568.0 (2021), compared with a mean of -$14411.6.
  • The widest YoY moves for Exchange Rate Effect: up 1283.72% in 2022, down 3654.3% in 2022.
  • China Pharma Holdings' Exchange Rate Effect stood at -$14578.0 in 2021, then soared by 126.57% to $3874.0 in 2022, then soared by 1201.99% to $50439.0 in 2023, then plummeted by 225.7% to -$63400.0 in 2024, then surged by 106.08% to $3856.0 in 2025.
  • The last three reported values for Exchange Rate Effect were $3856.0 (Q4 2025), $42392.0 (Q3 2025), and -$39627.0 (Q2 2025) per Business Quant data.